2San has partnered with Proov to distribute their at-home fertility tests in select Hy-Vee stores across eight states in the Midwest.
Proov’s range of tests offers a comprehensive fertility baseline assessment with its four products: Reserve (follicle stimulating hormone), Predict (luteinizing hormone), Confirm (PdG) and Check (human chorionic gonadotropin) products, which enable women to measure their major fertility hormones providing insight into the hormonal factors underlying: ovarian reserve; peak fertility, ovulation; implantation and confirmation of pregnancy, respectively, at an affordable price.
“Many products are positioned as the answer to fertility issues when they only provide half the picture of what may be going with their reproductive system,” said Proov’s founder Amy Beckley. “Proov begins to fill that critical gap in knowledge for people trying to conceive. We are thrilled to have a partner like 2San who have the same values of empowering people to lead better lives, providing them with products that are accessible, affordable and high-quality.”
Beckley, having suffered seven miscarriages and choosing to undergo multiple rounds of IVF, created Proov primarily to help women take their fertility journeys into their own hands.
2San operates internationally with a team of clinical experts and distribution specialists. A leading supplier of self-diagnostic test kits worldwide, Proov is the first of several products 2San will distribute in the fertility space.
“We are continuously scouring the globe to bring novel solutions and digital technologies to market that transform lives and empower people everywhere to own their health,” said Valerie Palmieri, member of the 2San scientific advisory committee. “Proov’s innovative fertility at-home tests provide a way for people to take their fertility journey into their own hands. We are excited to be the exclusive partner in distributing these products to stores nationwide.”
This summer 2San will also distribute a novel male fertility test that measures the key indicators of male fertility, of which there are no competing products on the market. SwimCount will expand the male fertility market and also give men the ability to take control of their fertility, the company said.